(Q46114213)

19 December 2017

review article

1 reference

title

Did grandma give you heart disease? The new battle against coronary artery disease (English)

1 reference

19 December 2017

author name string

H R Superko

series ordinal

1

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

19 December 2017

American Journal of Cardiology

published in

1 reference

19 December 2017

volume

82

1 reference

19 December 2017

issue

9A

1 reference

19 December 2017

page(s)

34Q-46Q

1 reference

19 December 2017

Beyond LDL cholesterol reduction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Familial occurrence of coronary heart disease: Effect of age at diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Coronary risk associated with age and sex of parental heart disease in the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

The new thinking on lipids and coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Ischemic heart disease, atherosclerosis, and longevity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Lipoprotein (a). Heterogeneity and biological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Lipoprotein(a). A genetic risk factor for premature coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Effect of fluvastatin on low-density lipoprotein peak particle diameter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Lipoprotein(a) reduction by N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Folic acid--an innocuous means to reduce plasma homocysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Cost-effective treatment of coronary artery disease--the new imperative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Failure of cholesterol treatment in patients with coronary artery disease: a cost-effective solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900771-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(98)00771-1

1 reference

19 December 2017

1 reference

19 December 2017